Karlsson D, Fallarero A, Shinde P, Anju CP, Busygin I, Leino R, Mohan CG, Vuorela P (2014)
Chemical modifications of cinchona alkaloids lead to enhanced inhibition of human butyrylcholinesterase
Nat Prod Commun 9: 455

Prinz M, Parlar S, Bayraktar G, Alptuzun V, Erciyas E, Fallarero A, Karlsson D, Vuorela P, Burek M, Forster C, Turunc E, Armagan G, Yalcin A, Schiller C, Leuner K, Krug M, Sotriffer CA, Holzgrabe U (2013)
1,4-Substituted 4-(1H)-pyridylene-hydrazone-type inhibitors of AChE, BCHE, and amyloid-beta aggregation crossing the blood-brain barrier
Eur J Pharm Sci 49: 603

Brunhofer G, Fallarero A, Karlsson D, Batista-Gonzalez A, Shinde P, Gopi Mohan C, Vuorela P (2012)
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: The case of chelerythrine
Bioorganic & Medicinal Chemistry 20: 6669

Karlsson D, Fallarero A, Brunhofer G, Guzik P, Prinz M, Holzgrabe U, Erker T, Vuorela P (2012)
Identification and characterization of diarylimidazoles as hybrid inhibitors of butyrylcholinesterase and amyloid beta fibril formation
Eur J Pharm Sci 45: 169

Karlsson D, Fallarero A, Brunhofer G, Mayer C, Prakash O, Mohan CG, Vuorela P, Erker T (2012)
The exploration of thienothiazines as selective butyrylcholinesterase inhibitors
Eur J Pharm Sci 47: 190

Gupta S, Fallarero A, Jarvinen P, Karlsson D, Johnson MS, Vuorela PM, Mohan CG (2011)
Discovery of dual binding site acetylcholinesterase inhibitors identified by pharmacophore modeling and sequential virtual screening techniques
Bioorganic & Medicinal Chemistry Lett 21: 1105